Cleerly LABS vs Ligence Heart
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify and characterize atherosclerosis and stenosis. This tool is ideal for clinicians focused on personalized heart disease management, risk assessment, and tracking the progression of coronary artery disease over time through advanced CCTA imaging.
View Cleerly LABS →Choose Ligence Heart if…
Choose Ligence Heart if you aim to significantly enhance the efficiency and accuracy of your 2D transthoracic echocardiography analysis and reporting. This platform is best suited for cardiology practices and sonography departments seeking to automate measurements, classify views, and generate standardized reports for a wide range of cardiac conditions, thereby streamlining their echo workflow.
View Ligence Heart →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Ligence Heart |
|---|---|---|
| Pricing | Per analysis | Contact-for-pricing |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-based; on-premise; hybrid |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartLigence Heart emphasizes 'automated recognition' and 'automated report generation,' which directly reduces manual effort and enhances diagnostic efficiency for cardiologists and sonographers. The description also highlights its intuitive interface and the elimination of manual tracing, suggesting a smoother user experience.
Clinical Value
Cleerly LABSCleerly LABS offers a more proactive and potentially higher-impact clinical value by focusing on the early detection, detailed characterization, and progression tracking of coronary atherosclerosis via CCTA, aiming to prevent heart attacks. This personalized approach to heart disease management, including ischemia detection, addresses a critical unmet need in cardiovascular care.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing information, even if the cost can be significant for patients, allowing potential users to better evaluate the financial commitment and value proposition upfront. Ligence Heart's 'contact-for-pricing' model makes it impossible to assess its value without direct engagement.
Enterprise Readiness
Ligence HeartLigence Heart offers greater deployment flexibility with cloud, on-premise, and hybrid options, which is a significant advantage for enterprises with diverse IT infrastructure and data governance requirements. Both tools demonstrate strong compliance and integration capabilities, but Ligence's deployment versatility edges it out.
Innovation
Cleerly LABSCleerly LABS demonstrates higher innovation by pioneering a comprehensive, AI-driven approach to characterize and track coronary plaque from CCTA, aiming to fundamentally change how coronary artery disease is managed and ultimately prevent heart attacks. This goes beyond optimizing existing workflows to establish a new standard of care.
Support & Docs
Ligence HeartLigence Heart appears to offer more comprehensive and readily accessible support resources, including explicit mentions of user manuals, installation manuals, and training videos for operators. This robust documentation and training approach suggests a stronger commitment to user self-service and onboarding support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Ligence Heart |
|---|---|---|
| Primary Imaging Modality | Coronary CT Angiography (CCTA) | 2D Transthoracic Echocardiography |
| Core Functionality | AI-powered CCTA analysis to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered platform for automated analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy. |
| Key Analysis Capabilities | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries. | Automated view classification and heart phase prediction, automated calculation of measurements and report generation, disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), automated strain, Spectral and Tissue Doppler measurements. |
| Integration | Integration with PACS, RIS, EHR via Cleerly Proxy. | Integration with existing systems (PACS, EHR, RIS). |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Ligence Heart.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Ligence Heart
Backers
Who funded each tool's parent company.